Advertisement
Australia markets open in 6 hours 9 minutes
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • AUD/USD

    0.6420
    -0.0017 (-0.26%)
     
  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     
  • OIL

    82.86
    +0.17 (+0.21%)
     
  • GOLD

    2,398.50
    +10.10 (+0.42%)
     
  • Bitcoin AUD

    98,357.39
    +3,441.72 (+3.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb

Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb

In particular, GlaxoSmithKline (NYSE: GSK) and Bristol-Myers Squibb (NYSE: BMY) are two of the world's most preeminent pharmaceutical companies, but neither has consistently outperformed the market over the past five years. Right now, Bristol-Myers is in the doldrums. Over the past three years, its quarterly revenue has jumped 94.6% and quarterly net income has risen 33.3%.